Oral Cancer Surgery and COVID pandemic - Metronomic Therapy shows a promising role while awaiting surgery
- PMID: 32451171
- PMCID: PMC7255261
- DOI: 10.1016/j.oraloncology.2020.104814
Oral Cancer Surgery and COVID pandemic - Metronomic Therapy shows a promising role while awaiting surgery
Abstract
- •
Metronomic therapy is a good option for locally advanced oral cancers in COVID-19 pandemic time.
- •
In the present situation there is a need for a therapy that ensure patients remain operable while awaiting surgery.
- •
Metronomic therapy is easily deliverable, minimally toxic, home based and cost effective.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Comment in
-
Methotrexate based oral chemotherapy for advanced oral cancer during COVID-19 pandemic: Another option in the therapeutic armamentarium.Oral Oncol. 2020 Aug;107:104839. doi: 10.1016/j.oraloncology.2020.104839. Epub 2020 Jun 4. Oral Oncol. 2020. PMID: 32513628 Free PMC article. No abstract available.
Comment on
-
Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection.EClinicalMedicine. 2020 Apr 5;21:100331. doi: 10.1016/j.eclinm.2020.100331. eCollection 2020 Apr. EClinicalMedicine. 2020. PMID: 32292899 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
